PER2 and neoplasm: To determine whether PER2 oscillations had an impact on response to therapy as we found out in human eSCC cells, we treated mouse tumor epithelial cells with cisplatin for 4 h when PER2 expression is high (24 and 48 h) or when it is low (36 and 60 h) (Figure 6D).